NCT03819569View on ClinicalTrials.gov

GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses

NACompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

April 18, 2024

Study Completion Date

April 18, 2024

Conditions
Small Renal MassKidney Tumor
Interventions
PROCEDURE

Small Renal Mass Biopsy

Subjects will receive a small renal mass biopsy prior to making a treatment decision

OTHER

No Small Renal Mass Biopsy

Subjects will not receive a small renal mass biopsy prior to making a treatment decision

Trial Locations (1)

27599

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

All Listed Sponsors
lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT03819569 - GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses | Biotech Hunter | Biotech Hunter